<DOC>
	<DOCNO>NCT01151085</DOCNO>
	<brief_summary>To collect efficacy safety information voriconazole related appropriate use daily practice .</brief_summary>
	<brief_title>Voriconazole ( Vfend ) Drug Use Investigation ( Regulatory Post Marketing Commitment Plan )</brief_title>
	<detailed_description>All subject investigator prescribes first voriconazole ( VFEND ) register consecutively number subject reach target number order extract subject enrol investigation random .</detailed_description>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Male Female subject intend treat deep mycosis prescribe voriconazole ( VFEND ) Physicians . Subject heve prescribe voriconazole ( VFEND ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Systemic Mycosis</keyword>
	<keyword>Aspergillus infection</keyword>
	<keyword>Candidiasis</keyword>
	<keyword>Cryptococcal infection</keyword>
	<keyword>Japanese</keyword>
	<keyword>voriconazole</keyword>
	<keyword>VFEND</keyword>
	<keyword>Regulatory Post Marketing Commitment Plan .</keyword>
</DOC>